Page 369 - Binder2
P. 369
Chapter 7: Reinventing Drug
Delivery
The Future of Biologics Doesn’t Look Like the Past
7.0 – Introduction: A System Built for the Wrong
Kind of Drugs
Drug delivery is more than a logistical problem—it’s an
architectural one.
Every drug is born into an ecosystem of constraints: how
it’s manufactured, how it’s stabilized, how it reaches the
body, and who gets to receive it. For biologics—complex
molecules derived from living systems—that architecture
has become both a marvel and a trap.
The current delivery infrastructure was built around
injectable, fragile, and high-cost therapies. It assumes:
• That a cold chain is necessary.
• That administration requires clinical oversight.
• That risk justifies gatekeeping.
This architecture has produced monumental advances—
life-extending treatments for cancer, autoimmunity, and
rare genetic disorders. But it has also produced an
ecosystem that is:
• Inaccessible to many.
• Expensive by design.
• Slow to adapt.
367
